Abbott-arkiv - BioStock

Roche acquisition

Prolight‘s CEO: “Roche’s acquisition highlights interest in Point-of-Care”

29 January, 2024

Cereno Scientific brings CVD expertise to CVCT Forum

Cereno Scientific brings CVD expertise to CVCT Forum

2 December, 2021

Cereno Scientific IND acceptance

Cereno Scientific receives IND acceptance for phase II start

21 September, 2021

BioStock Studio: Cereno’s CEO is looking forward to trial start

26 August, 2021